See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 18, 2006

Keratoses Asthma Diabetes - Type 1

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:


If you have actinic keratoses (AK) on your face, ears, or scalp, you may be eligible to participate in a clinical study of a new topical medication. Volunteers 18 or older who have at least five visible AK lesions on the face, ears, or scalp and have not received treatment for AK within the past two months may qualify.

The research site is in San Antonio, Texas.

More information

Please see



If you have mild-to-moderate asthma but are otherwise in good health, you may qualify for a clinical study of an investigational medication. Candidates must be 18-50, diagnosed with asthma for at least the past year, and must be non-smokers or previous smokers currently on inhaled corticosteroids. Participants will receive all study-related exams and investigational medication at no cost and may be compensated up to $2,350 for time and travel.

The research site is in San Diego, Calif.

More information

Please see


Diabetes - Type 1

Diabetics at least 18 who also have albuminuria (protein in the urine) may qualify for this research study. Volunteers cannot be using diltiazam or verapamil, cannot have HIV, and cannot be pregnant, breastfeeding or intend to become pregnant during the study.

The research site is in Bronx, N.Y.

More information

Please see


Copyright 2006 CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.